Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway

BMC Systems Biology

Volumn 3, Issue , 2009, Pages 100-

  Orton, Richard J ^a   Adriaens, Michiel E ^a,b   Gormand, Amelie ^a,c   Sturm, Oliver E ^a,d   Kolch, Walter ^e   Gilbert, David R ^a,f  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LUND UNIVERSITY   (Sweden)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^f BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EGFR PROTEIN, RAT; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL STRAIN; COMPUTER SIMULATION; GENETICS; METABOLISM; MUTATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; COMPUTER SIMULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MODELS, BIOLOGICAL; MUTATION; PC12 CELLS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 70449513896     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-3-100     Document Type: Article

References (44)

1. Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, Kolch W. Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem J 2005, 392(Pt 2):249-261. 1316260, 16293107.
2. Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 2006, 24(1):21-44. 10.1080/02699050500284218, 16393692.
3. Langlois WJ, Sasaoka T, Saltiel AR, Olefsky JM. Negative feedback regulation and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation. J Biol Chem 1995, 270(43):25320-25323. 10.1074/jbc.270.43.25320, 7592690.
4. Waters SB, Holt KH, Ross SE, Syu LJ, Guan KL, Saltiel AR, Koretzky GA, Pessin JE. Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J Biol Chem 1995, 270(36):20883-20886. 10.1074/jbc.270.36.20883, 7673108.
5. Dong C, Waters SB, Holt KH, Pessin JE. SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways. J Biol Chem 1996, 271(11):6328-6332. 10.1074/jbc.271.11.6328, 8626428.
6. Corbalan-Garcia S, Yang SS, Degenhardt KR, Bar-Sagi D. Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol Cell Biol 1996, 16(10):5674-5682. 231567, 8816480.
7. Douville E, Downward J. EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2. Oncogene 1997, 15(4):373-383. 10.1038/sj.onc.1201214, 9242373.
8. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 1992, 288(Pt 2):351-355. 1132018, 1334404.
9. Kao S, Jaiswal RK, Kolch W, Landreth GE. Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 2001, 276(21):18169-18177. 10.1074/jbc.M008870200, 11278445.
10. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 1994, 4(8):694-701. 10.1016/S0960-9822(00)00154-8, 7953555.
11. Brightman FA, Fell DA. Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Lett 2000, 482(3):169-174. 10.1016/S0014-5793(00)02037-8, 11024454.
12. Santos SD, Verveer PJ, Bastiaens PI. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 2007, 9(3):324-330. 10.1038/ncb1543, 17310240.
13. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989, 49(17):4682-4689.
14. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W. Mutations of the BRAF gene in human cancer. Nature 2002, 417(6892):949-954. 10.1038/nature00766, 12068308.
15. Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 1997, 8(12):1197-1206. 10.1023/A:1008209720526, 9496384.
16. Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH, Bigner DD. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci USA 1990, 87(11):4207-4211. 10.1073/pnas.87.11.4207, 54077, 1693434.
17. Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, McLendon RE, Moscatello D, Pegram CN, Reist CJ. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res 1995, 55(14):3140-3148.
18. Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res 1995, 55(23):5536-5539.
19. Huang HS, Nagane M, Klingbeil CK, Lin H, Nishikawa R, Ji XD, Huang CM, Gill GN, Wiley HS, Cavenee WK. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 1997, 272(5):2927-2935. 10.1074/jbc.272.5.2927, 9006938.
20. Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS, Bigner DD. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 1990, 50(24):8017-8022.
21. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res 1988, 48(8):2231-2238.
22. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 1985, 313(5998):144-147. 10.1038/313144a0, 2981413.
23. Xu YH, Richert N, Ito S, Merlino GT, Pastan I. Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Acad Sci USA 1984, 81(23):7308-7312. 10.1073/pnas.81.23.7308, 392135, 6095284.
24. Schmidt MH, Furnari FB, Cavenee WK, Bogler O. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization. Proc Natl Acad Sci USA 2003, 100(11):6505-6510. 10.1073/pnas.1031790100, 164476, 12734385.
25. Huang CY, Ferrell JE. Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1996, 93(19):10078-10083. 10.1073/pnas.93.19.10078, 38339, 8816754.
26. Burack WR, Sturgill TW. The activating dual phosphorylation of MAPK by MEK is nonprocessive. Biochemistry 1997, 36(20):5929-5933. 10.1021/bi970535d, 9166761.
27. Ferrell JE, Bhatt RR. Mechanistic studies of the dual phosphorylation of mitogen-activated protein kinase. J Biol Chem 1997, 272(30):19008-19016. 10.1074/jbc.272.30.19008, 9228083.
28. Schoeberl B, Eichler-Jonsson C, Gilles ED, Muller G. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol 2002, 20(4):370-375. 10.1038/nbt0402-370, 11923843.
29. Brown KS, Hill CC, Calero GA, Myers CR, Lee KH, Sethna JP, Cerione RA. The statistical mechanics of complex signaling networks: nerve growth factor signaling. Physical Biology 2004, 1:184-195. 10.1088/1478-3967/1/3/006, 16204838.
30. Sasagawa S, Ozaki Y, Fujita K, Kuroda S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 2005, 7(4):365-373. 10.1038/ncb1233, 15793571.
31. Le Novere N, Bornstein B, Broicher A, Courtot M, Donizelli M, Dharuri H, Li L, Sauro H, Schilstra M, Shapiro B. BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems. Nucleic Acids Res 2006, (34 Database):D689-691. 10.1093/nar/gkj092, 1347454, 16381960.
32. Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, Singhal M, Xu L, Mendes P, Kummer U. COPASI--a COmplex PAthway SImulator. Bioinformatics 2006, 22(24):3067-3074. 10.1093/bioinformatics/btl485, 17032683.
33. Orton RJ, Sturm OE, Gormand A, Wolch W, Gilbert DR. Computational modelling reveals feedback redundancy within the epidermal growth factor receptor/extracellular-signal regulated kinase signalling pathway. IET Syst Biol 2008, 2(4):173-183. 10.1049/iet-syb:20070066, 18681747.
34. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003, 19(4):524-531. 10.1093/bioinformatics/btg015, 12611808.
35. Chen YR, Fu YN, Lin CH, Yang ST, Hu SF, Chen YT, Tsai SF, Huang SF. Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene 2006, 25(8):1205-1215. 10.1038/sj.onc.1209159, 16205628.
36. Gao L, Feng Y, Bowers R, Becker-Hapak M, Gardner J, Council L, Linette G, Zhao H, Cornelius LA. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res 2006, 66(16):7880-7888. 10.1158/0008-5472.CAN-06-0254, 16912161.
37. De Falco V, Castellone MD, De Vita G, Cirafici AM, Hershman JM, Guerrero C, Fusco A, Melillo RM, Santoro M. RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer Res 2007, 67(1):381-390. 10.1158/0008-5472.CAN-06-0981, 17210721.
38. Kholodenko BN, Demin OV, Moehren G, Hoek JB. Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 1999, 274(42):30169-30181. 10.1074/jbc.274.42.30169, 10514507.
39. Pinney J, Westhead D, McConkey G. Petri Net representations in systems biology. Biochemical Society Transactions 2003, 31:1513-1515. 10.1042/BST0311513, 14641101.
40. Oliveira JS, Jones-Oliveira JB, Dixon DA, Bailey CG, Gull DW. Hyperdigraph-theoretic analysis of the EGFR signaling network: initial steps leading to GTP:Ras complex formation. J Comput Biol 2004, 11(5):812-842. 10.1089/cmb.2004.11.812, 15700404.
41. Chabrier N, Fages F. Symbolic model checking of biochemical networks. Lecture Notes in Computer Science 2003, 2602:149-162.
42. Calder M, Gilmore S, Hillston J. Modelling the influence of RKIP on the ERK signalling pathway using the stochastic process algebra PEPA. Proceedings of Bio-Concur 2004, 1:36-49.
43. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJ. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 1998, 392(6676):622-626. 10.1038/33451, 9560161.
44. Box GEP, Draper NR. Empirical Model-Building and Response Surfaces. 1987, Wiley, New York.